Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Diabetes Prevention Program Outcomes Study Reports 22-year Results
New data from the Diabetes Prevention Outcomes Study shows persistent reduction of type 2 diabetes development over 22-year average follow-up.
Long-term follow-up of participants enrolled in the Diabetes Prevention Program Outcomes Study (DPPOS) demonstrates a significant and persistent reduction in risk for type 2 diabetes. The latest DPPOS results were presented at the American Diabetes Association 80th Virtual Scientific Sessions. The DPP/DPPOS is the largest and longest running diabetes prevention study that continues to actively follow participants.
In the short slide show below, find highlights from the symposium, “New Data on Clinical Outcomes from the Diabetes Prevention Program Outcomes Study (DPPOS).”
Recent Videos
Related Content
